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Background
 
Müllerian inhibiting substance, pro-
duced constitutively by the prepubertal testes, pro-
motes involution of the müllerian ducts during normal
male sexual differentiation. In children with viriliza-
tion and nonpalpable gonads, only those with testic-
ular tissue should have detectable serum concentra-
tions of müllerian inhibiting substance.
 
Methods
 
We measured serum müllerian inhibiting
substance in 65 children with virilization at birth and
nonpalpable gonads (age at diagnosis, 2 days to 11
years) and serum testosterone in 54 of them either
after the administration of human chorionic gonad-
otropin or during the physiologic rise in testosterone
that occurs in normal infants.
 
Results
 
The mean (
 

 
SD) serum müllerian inhibit-
ing substance concentration in the 17 children with
no testicular tissue was 0.7
 

 
0.5 ng per milliliter, as
compared with 37.5
 

 
39.6 ng per milliliter in the 48
children with testes (P
 

 
0.001). In the latter group,
the mean values in the 14 children with abnormal
testes and the 34 with normal testes were 11.5
 

 
11.8
and 48.2
 

 
42.1 ng per milliliter, respectively (P
 

 
0.001). The sensitivity and specificity of the serum
müllerian inhibiting substance assay for detecting
the absence of testicular tissue were 92 percent and
98 percent, respectively, as compared with 69 per-
cent and 83 percent for the measurement of serum
testosterone. Furthermore, measurement of serum
müllerian inhibiting substance was more sensitive
than serum testosterone measurement for the iden-
tification of children with abnormal testes (67 per-
cent vs. 25 percent), whereas the specificity of the
two tests was similar.
 
Conclusions
 
Measurements of serum müllerian
inhibiting substance can be used to determine testic-
ular status in prepubertal children with nonpalpable
gonads, thus differentiating anorchia from unde-
scended testes in boys with bilateral cryptorchidism
and serving as a measure of testicular integrity in
children with intersexual anomalies. (N Engl J Med
1997;336:1480-6.)
 
©1997, Massachusetts Medical Society.
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HE accurate identification of abdominal
gonads is essential for evaluating children
with virilization and nonpalpable gonads.
Gonadal biopsies provide definitive diag-
noses, but the gonads may be difficult to find, and
operative exploration is invasive and may compro-
mise the gonadal tissue. Radiologic imaging, though
T
 
noninvasive, may miss abdominal gonads.
 
1,2
 
 Meas-
urement of serum gonadotropins is helpful in ago-
nadal infants and peripubertal children but is often
nondiagnostic in midchildhood.
 
3,4
 
 Therefore, the
primary method of gonadal evaluation in prepuber-
tal children has been to determine the response of
serum testosterone to the administration of human
chorionic gonadotropin.
 
5-10
 
 The ability to detect a
circulating hormone produced constitutively by pre-
pubertal testes, but not ovaries, would obviate the
need for provocative testing.
Müllerian inhibiting substance,
 
11
 
 or anti-müllerian
hormone,
 
12
 
 a gonadal hormone that promotes the
involution of the müllerian ducts during normal
male sexual differentiation, is secreted in such a sex-
ually dimorphic pattern.
 
13
 
 The absence of müllerian
inhibiting substance in female embryos is necessary
for the müllerian ducts to differentiate into the uter-
us, oviducts, and upper vagina.
 
14
 
 Testicular secretion
of müllerian inhibiting substance commences by the
eighth week of gestation and persists postnatally,
whereas ovarian production starts after birth.
 
15
 
 Se-
rum concentrations of müllerian inhibiting substance
are readily detectable in boys from birth to puberty,
when the concentrations decline, but are negligible
in girls until puberty.
 
13,16-18
 
 We undertook this study
to determine whether measurements of serum mül-
lerian inhibiting substance would help identify ab-
dominal testes in boys with bilateral cryptorchidism
and facilitate gonadal evaluation in children with in-
tersexual disorders.
 
METHODS
 
Study Subjects
 
We studied 65 children ranging in age from 2 days to 11 years
who were referred to Massachusetts General Hospital (Boston),
Children’s Memorial Hospital (Chicago), or Kiyose Children’s
Hospital (Tokyo, Japan) for the evaluation of cryptorchidism or
ambiguous genitalia. Blood samples for the measurement of se-
rum müllerian inhibiting substance were obtained in conjunction
The New England Journal of Medicine 
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with the collection of samples for other laboratory studies, with
oral parental consent, according to approved institutional guide-
lines. All the children studied had no palpable gonads and were
virilized, with the phenotype ranging from clitoromegaly with
otherwise normal appearing female genitalia to normally devel-
oped male genitalia. All subsequently either underwent surgical
exploration or had spontaneous testicular descent. The assign-
ment of sex was based on the diagnosis, the degree of virilization,
the karyotype, and potential fertility and sexual function. The 65
children were ultimately grouped diagnostically as those with an-
orchia, abnormal testes, normal testes, or ovaries (Table 1).
 
Serum Müllerian Inhibiting Substance Assay
 
Serum müllerian inhibiting substance was measured by an en-
zyme-linked immunosorbent assay as described previously.
 
13,17,19
 
The limit of sensitivity of the assay was 0.5 ng per milliliter, and
the intraassay and interassay coefficients of variation were 9 per-
cent and 15 percent, respectively. Undetectable values were as-
signed a value of 0.5 ng per milliliter. The results in the 65 study
subjects were compared with those in 438 normal children of
similar ages (
 

 
1 month, 
 

 
1 month to 
 

 
24 months, 
 

 
2 years to
 

 
6 years, and 
 

 
6 years to 
 

 
12 years).
 
13
 
 The respective mean (and
lowest) values for boys in each of the successive age groups were
22.6 (3.2), 84.0 (6.4), 63.8 (7.0), and 43.0 (0.8) ng per milliliter,
and the respective mean values for girls were 0.6, 0.9, 1.4, and
2.7 ng per milliliter, with the majority of values being undetect-
able in girls.
 
Other Hormonal Assays
 
Serum testosterone was measured before and after the admin-
istration of two to six injections of human chorionic gonadotro-
pin at a dose of 1500 IU per square meter of body-surface area
in 44 of the children. The results were compared with published
data obtained with similar testing regimens.
 
6-8,10
 
 In 10 other chil-
dren, serum testosterone was measured basally during early infan-
cy, a period when the values in normal children are elevated
because the hypothalamic–pituitary–gonadal axis is transiently ac-
tivated.
 
20,21
 
 In the remaining children, serum testosterone was
measured basally at ages when the values are indistinguishable be-
tween boys and girls and therefore nondiagnostic. Serum testos-
terone was measured by radioimmunoassay in the clinical labora-
tories of the referring centers, as was serum follicle-stimulating
hormone.
 
Statistical Analysis
 
We used Kolmogorov–Smirnov statistics to compare the distri-
bution of serum müllerian inhibiting substance values among the
four groups of children. The 95 percent confidence intervals of
the test characteristics (sensitivity, specificity, and positive and
negative predictive values) were obtained with exact interval esti-
mation.
 
22,23
 
RESULTS
 
Serum Müllerian Inhibiting Substance Concentrations
 
Serum müllerian inhibiting substance concentra-
tions in the children with anorchia, abnormal testes,
normal testes, or ovaries are shown in Figure 1. The
mean values differed significantly among the four
groups (P
 

 
0.001), except between the children with
anorchia and those with ovaries.
None of the 12 children with anorchia had iden-
tifiable gonadal tissue at surgery. Three had mi-
crophallus, but nine had normal phallic development.
All had low or undetectable serum concentrations of
müllerian inhibiting substance. Ten of these children
received stimulation with human chorionic gonado-
 
*Vanishing testes and testicular regression refer to children with a 46,XY
karyotype who have evidence of initial testicular formation with secondary
regression of the testes. The degree of virilization and the extent of residual
gonadal tissue vary and depend partly on the timing of the loss of testicular
function.
†This boy with 46,XXY Klinefelter’s syndrome was classified as having
cryptorchidism because he had normal external male genitalia and normal
immature testicular tissue on biopsy.
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Figure 1.
 
 Serum Müllerian Inhibiting Substance Concentrations
in Children with Anorchia, Abnormal Testes, Normal Testes,
and Ovaries.
The mean (
 

 
SD) serum müllerian inhibiting substance concen-
trations are listed below the graph for each group.
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tropin, which increased serum testosterone concen-
trations slightly to 40 ng per deciliter (1.39 nmol
per liter) in one but not in the other nine. Serum
follicle-stimulating hormone concentrations were el-
evated (for age) in nine and normal in three, but the
values did not correlate with those for either serum
testosterone or müllerian inhibiting substance.
Fourteen children had histologically abnormal tes-
tes and various degrees of genital virilization: 11 had
gonadal dysmorphogenesis including testicular dys-
genesis, streak gonads, ovotestes, and Leydig-cell hy-
poplasia, and 3 had bilateral intrauterine torsion with
gonadal atrophy. The mean (
 

 
SD) müllerian inhib-
iting substance concentration was 11.5
 

 
11.8 ng per
milliliter in this group, and the values were at or be-
low the fifth percentile of the values for normal chil-
dren in 10 (71 percent) of these children (Fig. 2).
In contrast, serum testosterone concentrations in-
creased after the administration of human chorionic
gonadotropin in all but one child. Eleven children in
this group had elevated basal or stimulated serum
testosterone concentrations of 59 to 405 ng per
deciliter (2.1 to 14.2 nmol per liter).
Thirty-four children had normal testes verified by
intraoperative examination, histologic assessment, or
palpation after spontaneous descent; 24 of these
children had bilateral cryptorchidism, and 10 had
male pseudohermaphroditism. Four boys with bilat-
eral cryptorchidism had hypospadias or microphal-
lus, and 20 had normal external male genitalia. The
extent of virilization of the children with male pseu-
dohermaphroditism ranged from mild clitoromegaly
to microphallus. The mean serum müllerian inhibit-
ing substance concentration in these children was
48.2
 

 
42.1 ng per milliliter. The values were all with-
in the normal range for boys, and only three were at
or below the fifth percentile for age (Fig. 2). Of the
27 boys in whom serum testosterone values were
measured after the administration of human chori-
onic gonadotropin, 19 (70 percent) had normal in-
creases for age and 8 (30 percent) had subnormal
increases. In two other boys with bilateral cryptor-
chidism, the basal serum testosterone values were el-
evated.
All five girls with female pseudohermaphroditism
had undetectable serum müllerian inhibiting sub-
stance concentrations, whereas basal serum testoster-
one concentrations were elevated in three of the girls
with a diagnosis of congenital adrenal hyperplasia.
Serum concentrations of müllerian inhibiting sub-
stance and testosterone were discordant in other
children besides these girls. In four boys with bilat-
eral cryptorchidism, serum müllerian inhibiting sub-
stance values were normal although serum testos-
terone values failed to increase with stimulation,
whereas in four children with mixed gonadal dys-
genesis and one with true hermaphroditism, serum
müllerian inhibiting substance values were low but
basal or stimulated serum testosterone concentra-
tions were elevated.
 
Determination of Testicular Status
 
The mean serum müllerian inhibiting substance
concentration in the 12 children with anorchia and
the 5 children with ovaries was significantly lower
than that in the 48 children with abnormal or nor-
mal testes (0.7
 

 
0.5 vs. 37.5
 

 
39.6 ng per milliliter,
P
 

 
0.001). The serum müllerian inhibiting substance
concentration was both a sensitive and a specific in-
dicator of the absence of testes (Table 2). The pre-
dictive value of a low concentration for the absence
of testes was 89 percent, and that of a normal value
for the presence of testes was 98 percent.
To compare the usefulness of serum müllerian in-
hibiting substance and testosterone determinations
for identifying testicular tissue, a similar analysis was
performed in 54 children in whom serum testoster-
one values were measured after stimulation with hu-
man chorionic gonadotropin in 44 and during the
physiologic testosterone rise that occurs in normal
infants in 10.
 
20,21
 
 Serum testosterone values were clas-
sified as normal if they were elevated above those
present in females in the appropriate age group. The
sensitivity and specificity of the müllerian inhibiting
substance assay in this subgroup of children were
similar to those in the entire group (Table 2). The
sensitivity and specificity of the serum testosterone
assay were 69 percent and 83 percent, respectively.
Although the positive predictive value of a low se-
rum testosterone value for the absence of testicular
tissue was only 56 percent, normal serum müllerian
 
Figure 2.
 
 Serum Müllerian Inhibiting Substance Concentrations
as a Function of Age in Children with Abnormal Testes and
Those with Normal Testes.
The dotted line represents the fifth percentile of the values rel-
ative to age in normal boys.
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inhibiting substance and testosterone values were
both highly predictive of the presence of testicular
tissue. The sensitivity and specificity of the combi-
nation of both tests for detecting the absence of tes-
tes were 62 percent and 100 percent, respectively.
 
Discriminating between Abnormal and Normal Testes
 
Among the 48 children with testicular tissue (14
with abnormal testes and 34 with normal testes), the
sensitivity and specificity of the serum müllerian in-
hibiting substance assay for identifying abnormal
testes were 71 percent and 91 percent, respectively
(Table 3). For the presence of abnormal testes, the
predictive value of a concentration below the fifth
percentile for normal boys was 77 percent. For the
presence of normal testes, the predictive value of a
concentration at or above the fifth percentile was 89
percent.
Among the 41 children with testicular tissue in
whom serum testosterone was measured, the sensi-
tivity and specificity of the müllerian inhibiting sub-
stance assay were similar to those in the larger group
of 48 children (Table 3). Serum testosterone values
were classified as normal if basal values obtained
during the physiologic peak that occurs in normal
infants or values measured after stimulation with
chorionic gonadotropin were in the normal range
for boys.
 
6-8,10
 
 The serum testosterone assay was not
sensitive (25 percent) in this group and was a poor
predictor of abnormal testes (27 percent). Using
both tests together decreased their sensitivity and
increased their specificity. Therefore, the combina-
tion of low serum müllerian inhibiting substance
and testosterone values was 100 percent predictive
of abnormal testes, but there was only one child in
this category.
 
DISCUSSION
 
These results demonstrate that measurement of
serum müllerian inhibiting substance is a sensitive
and specific test for the detection of testes in prepu-
bertal children. A measurable value within the nor-
mal range for boys is predictive of testicular tissue,
and an undetectable value is predictive of anorchia
or ovaries. Serum concentrations of müllerian inhib-
iting substance differ quantitatively in children with
abnormal and normal testes and, therefore, are also
helpful for assessing the structural integrity of the
testes. As compared with testing involving the ad-
ministration of human chorionic gonadotropin, the
measurement of serum müllerian inhibiting sub-
stance is more sensitive and equally specific, and its
predictive value for the absence of testicular tissue is
higher. Measurement of serum müllerian inhibiting
substance is particularly useful in young children,
because serum gonadotropin concentrations in those
 
*MIS denotes müllerian inhibiting substance, PPV positive predictive value, NPV negative predictive value, and CI
confidence interval. Serum müllerian inhibiting substance values were considered normal if they were within the normal
range for boys. 
†Ten of the serum testosterone values were obtained basally during the physiologic peak that occurs in normal infants.
All other values were obtained after the administration of human chorionic gonadotropin. Serum testosterone values were
considered normal if they were above the normal range for girls.
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VARIABLE ALL CHILDREN CHILDREN IN WHOM SERUM TESTOSTERONE WAS MEASURED
SERUM MIS SERUM MIS
SERUM 
TESTOSTERONE†
MIS AND
TESTOSTERONE
Low Normal Low Normal Low Normal
Both
Low
Either
Normal
Testes
Absent
Present
16
2
1
46
12
1
1
40
9
7
4
34
8
0
5
41
SENSITIVITY OF
TEST FOR 
ABSENT TESTES
SPECIFICITY OF TEST 
FOR TESTES PPV OF TEST NPV OF TEST
percent (95 percent CI)
All children
Serum MIS assay 94 (71–100) 96 (86–100) 89 (65–99) 98 (89–100)
Children in whom serum testos-
terone was measured 
Serum MIS assay
Serum testosterone test
Both tests
92 (64–100)
69 (39–91)
62 (32–86)
98 (87–100)
83 (68–93)
100 (91–100)
92 (64–100)
56 (30–80)
100 (63–100)
98 (87–100)
90 (75–97)
89 (76–96)
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who are agonadal are nondiagnostic in midchild-
hood4 and serum testosterone concentrations may
fail to increase with provocative testing in children
with abdominal testes, as found in this study. Meas-
urement of serum müllerian inhibiting substance is
also simpler, requiring only a single blood sample,
than testing with human chorionic gonadotropin.
The presence of müllerian inhibiting substance in
serum is a highly specific marker of testicular tissue
in infants and prepubertal children.13,19,24,25 With pu-
bertal maturation, testicular synthesis of this hor-
mone declines, whereas ovarian synthesis increases,
and serum concentrations overlap in men and wom-
en.13,26,27 Nevertheless, values above the normal range
for women remain diagnostic of the presence of tes-
ticular tissue except in women with granulosa-cell
tumors or sex-cord tumors that secrete müllerian in-
hibiting substance.28,29 Conversely, serum müllerian
inhibiting substance concentrations may be low in a
subgroup of children with the rare syndrome of per-
sistent müllerian ducts despite the presence of struc-
turally normal testes.30 
Müllerian inhibiting substance is produced and
secreted by Sertoli cells, and testosterone is pro-
duced and secreted by Leydig cells. Thus, the dis-
cordant serum müllerian inhibiting substance and
testosterone values in some of the children in the
study may reflect the disparate effects of abdominal-
ly positioned testes or gonadal dysgenesis on Sertoli
and Leydig cells. Testicular function has traditionally
been assessed by examining the steroidogenic capac-
ity of Leydig cells and spermatogenesis. Assessment
of the function of immature Sertoli cells may also be
relevant, however, because Sertoli cells constitute the
supporting cellular matrix for spermatogenesis and
an adequate complement in the developing testes
may be critical for the survival and maturation of
germ cells.31 Long-term follow-up of the children
with discordant results may resolve whether func-
tional assessment of Sertoli cells or Leydig cells be-
fore puberty will be the better predictor of mature
testicular function.
Several questions may arise during the evaluation
of children with virilization and nonpalpable go-
nads. Are gonads present, and if so, are they normal?
What is the potential for sexual and reproductive
function? Is surgical exploration necessary? In this
study, we found that measurement of serum müller-
ian inhibiting substance is a clinically useful and
convenient test that can help answer these questions.
We suggest that the test can best be used as outlined
in Figure 3. In boys with bilateral cryptorchidism,
determination of serum müllerian inhibiting sub-
stance should distinguish those with anorchia from
those with abdominal testes; a value in the normal
range for boys is sufficient to confirm that testicular
tissue is present. Consequently, surgical exploration
is necessary if the testes fail to descend spontaneous-
*MIS denotes müllerian inhibiting substance, 5th percentile fifth percentile of the value relative to age in normal boys,
PPV positive predictive value, NPV negative predictive value, and CI confidence interval.
†Seven of the serum testosterone values were obtained basally during the physiologic peak that occurs in normal infants.
All other values were obtained after the administration of human chorionic gonadotropin. Serum testosterone values were
classified as normal if basal values obtained during the physiologic peak that occurs in normal infants or values measured
after stimulation with chorionic gonadotropin were in the normal range for boys.6-8,10
TABLE 3. VALUE OF SERUM MÜLLERIAN INHIBITING SUBSTANCE ASSAY FOR DISTINGUISHING
BETWEEN ABNORMAL AND NORMAL TESTES.*
VARIABLE ALL CHILDREN CHILDREN IN WHOM SERUM TESTOSTERONE WAS MEASURED
SERUM MIS SERUM MIS
SERUM 
TESTOSTERONE†
MIS AND
TESTOSTERONE
5th
Percentile
5th
Percentile
5th
Percentile
5th
Percentile Low Normal
Both
Low
Either
Normal
Testes
Abnormal
Normal
10
3
4
31
8
3
4
26
3
8
9
21
1
0
11
29
SENSITIVITY OF
TEST FOR
ABNORMAL TESTES
SPECIFICITY OF
TEST FOR
NORMAL TESTES PPV OF TEST NPV OF TEST
percent (95 percent CI)
All children
Serum MIS assay 71 (47–92) 91 (76–98) 77 (46–95) 89 (73–97)
Children in whom serum 
testosterone was measured
Serum MIS assay
Serum testosterone test
Both tests
67 (35–90)
25 (6–57)
8 (0.2–39)
90 (73–98)
72 (53–87)
100 (88–100)
73 (39–94)
27 (6–61)
100 (3–100)
87 (69–96)
70 (51–85)
73 (56–85)
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ly during infancy. Conversely, if the serum müllerian
inhibiting substance value is low, serum testosterone
should be measured before and after the administra-
tion of human chorionic gonadotropin to verify the
absence of testicular tissue or identify other cases of
cryptorchidism. In children with intersexual disor-
ders, the serum müllerian inhibiting substance value
is a measure of the structural integrity of the gonads
that helps delineate the cause of the disorder. A val-
ue in the normal range for boys indicates that mor-
phologically normal testes are present and suggests
that the child has a disorder of androgen action or
biosynthesis.32 A low value suggests that the testes
are dysgenetic, and an undetectable value suggests
that the testes are absent, as would be the case in
girls with female pseudohermaphroditism and pure
gonadal dysgenesis. In children with intersexual dis-
orders, measurement of serum müllerian inhibiting
substance offers an additional index of testicular
function but should not preclude testing involving
stimulation with human chorionic gonadotropin,
which is necessary for the definitive diagnosis of de-
fects in the synthesis of testosterone. Moreover, as a
highly specific test for the presence of testicular tis-
sue, measurement of serum müllerian inhibiting sub-
stance will effectively identify unwanted residual tes-
ticular tissue in girls with true hermaphroditism who
have undergone partial gonadectomies.19
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Figure 3. Interpretation of the Assay of Serum Müllerian Inhibiting Substance in the Evaluation of Boys
with Bilateral Undescended Testes or Children with Intersexual Disorders.
Boys with Bilateral Undescended Testes (Normal Phallus)
Serum müllerian inhibiting substance assay
Normal
levels
Undetectable
levels
Testes present
Operate to bring down testes
(or observe if 1 year of age)
Operate to bring down testes
(consider persistent müllerian
duct syndrome)
No surgery required
(anorchia)
Testes absent
Stimulate with human
chorionic gonadotropin
No testosterone
response
Increase in
testosterone
Children with Intersexual Disorders (Ambiguous Genitalia)
Serum müllerian inhibiting substance assay
Normal
levels
Low
levels
Undetectable
levels
Testes present Testicular dysgenesis
Male pseudohermaphroditism
   Androgen-resistance
      syndromes
   Defects in testosterone
      synthesis
   Idiopathic causes
   Secondary hypogonadism
Gonadal dysmorpho-
      genesis
   Mixed gonadal
      dysgenesis
   True hermaphroditism
Testicular regression
Female pseudohermaph-
      roditism
   Congenital adrenal
      hyperplasia
   Maternal factors
   Idiopathic causes
Pure gonadal dysgenesis
Vanishing testes
Testes absent
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müllerian inhibiting substance: Samir Najjar and Alan Retik
(Boston), Curtis Sheldon and Eric Smith (Cincinnati), Carolyn
Becker (Danbury, Conn.), Gary Freidenberg (Indianapolis), Mar-
tin Goldsmith (Fresno, Calif.), Jerome Grunt (Kansas City, Mo.),
Stuart Howards (Charlottesville, Va.), Robert McVie (Shreveport,
La.), Sharon Oberfeld (New York), Harold Starkman (Morristown,
N.J.), A. Winthrop (Hamilton, Ont., Canada), and Stephen Wolf
(Des Moines, Iowa); and to Ms. Laura Asmundson and Ms. Gretch-
en B. Crist for technical assistance.
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